Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Brunelli

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Journal of Molecular and Cellular Cardiology|September 24, 2004
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitroPaolo Spallarossa, Silvano Garibaldi, Paola Altieri, et al.
The Journal of Rheumatology|May 4, 2010
Brachial artery endothelial-dependent flow-mediated dilation identifies early-stage endothelial dysfunction in systemic sclerosis and correlates with nailfold microvascular impairmentDaniela Rollando, Gian Paolo Bezante, Alberto Sulli, et al.
Thrombosis and Haemostasis|June 28, 2013
The vulnerable coronary plaque: update on imaging technologiesGian Marco Rosa, Matteo Bauckneht, Giovanni Masoero, et al.
Plos One|May 9, 2015
Doxorubicin impairs the insulin-like growth factor-1 system and causes insulin-like growth factor-1 resistance in cardiomyocytesPatrizia Fabbi, Paolo Spallarossa, Silvano Garibaldi, et al.
Atherosclerosis|August 25, 2014
Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thicknessPietro Ameri, Marco Canepa, Patrizia Fabbi, et al.
Medicinal Research Reviews|December 29, 2017
Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effectsPaolo Spallarossa, Giovanni Meliota, Claudio Brunelli, et al.
The American Journal of Cardiology|January 20, 2012
Contribution of central adiposity to left ventricular diastolic function (from the Baltimore Longitudinal Study of Aging)Marco Canepa, James B Strait, Dmitry Abramov, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2009
Optimization of flow reserve measurement using SPECT technology to evaluate the determinants of coronary microvascular dysfunction in diabetesCecilia Marini, GianPaolo Bezante, Patrizia Gandolfo, et al.
Journal of Translational Medicine|October 26, 2018
An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracyclineMatteo Sarocchi, Matteo Bauckneht, Eleonora Arboscello, et al.
Scientific Reports|July 23, 2016
The human amniotic fluid stem cell secretome effectively counteracts doxorubicin-induced cardiotoxicityEdoardo Lazzarini, Carolina Balbi, Paola Altieri, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Journal of Molecular and Cellular Cardiology|September 24, 2004
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitroPaolo Spallarossa, Silvano Garibaldi, Paola Altieri, et al.
The Journal of Rheumatology|May 4, 2010
Brachial artery endothelial-dependent flow-mediated dilation identifies early-stage endothelial dysfunction in systemic sclerosis and correlates with nailfold microvascular impairmentDaniela Rollando, Gian Paolo Bezante, Alberto Sulli, et al.
Thrombosis and Haemostasis|June 28, 2013
The vulnerable coronary plaque: update on imaging technologiesGian Marco Rosa, Matteo Bauckneht, Giovanni Masoero, et al.
Plos One|May 9, 2015
Doxorubicin impairs the insulin-like growth factor-1 system and causes insulin-like growth factor-1 resistance in cardiomyocytesPatrizia Fabbi, Paolo Spallarossa, Silvano Garibaldi, et al.
Atherosclerosis|August 25, 2014
Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thicknessPietro Ameri, Marco Canepa, Patrizia Fabbi, et al.
Medicinal Research Reviews|December 29, 2017
Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effectsPaolo Spallarossa, Giovanni Meliota, Claudio Brunelli, et al.
The American Journal of Cardiology|January 20, 2012
Contribution of central adiposity to left ventricular diastolic function (from the Baltimore Longitudinal Study of Aging)Marco Canepa, James B Strait, Dmitry Abramov, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2009
Optimization of flow reserve measurement using SPECT technology to evaluate the determinants of coronary microvascular dysfunction in diabetesCecilia Marini, GianPaolo Bezante, Patrizia Gandolfo, et al.
Journal of Translational Medicine|October 26, 2018
An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracyclineMatteo Sarocchi, Matteo Bauckneht, Eleonora Arboscello, et al.
Scientific Reports|July 23, 2016
The human amniotic fluid stem cell secretome effectively counteracts doxorubicin-induced cardiotoxicityEdoardo Lazzarini, Carolina Balbi, Paola Altieri, et al.
Pageof 11